Elon's Vision
  • Contacts
  • Privacy Policy
  • Terms & Conditions
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Elon's Vision
No Result
View All Result
Home Investing

Former Asda boss Mohsin Issa invests £10m in sports supplement firm ahead of London IPO

by
October 16, 2024
in Investing
0
Former Asda boss Mohsin Issa invests £10m in sports supplement firm ahead of London IPO
0
SHARES
2
VIEWS
Share on FacebookShare on Twitter

Billionaire retail mogul Mohsin Issa, former CEO and co-owner of Asda, has made his first major investment since stepping down from the supermarket giant, putting £10 million into Liverpool-based sports supplements company, Applied Nutrition. The company is preparing to go public on the London Stock Exchange.

Issa’s investment in Applied Nutrition comes through his investment vehicle, Boulder Investco Limited, and marks his initial foray into new ventures following his departure from Asda’s leadership in September. His exit followed a dip in sales that was publicly criticised by Asda’s chairman, Lord Rose. Despite stepping down as CEO, Issa remains a co-owner of Asda with a 22.5% stake and holds a seat on the board.

This investment also signals a shift in Mohsin Issa’s business trajectory as he and his brother, Zuber Issa, untangle their joint business interests. The brothers, who are worth an estimated £5 billion, have built a vast empire, including petrol station operator Euro Garages, which became a launchpad for their £6.8 billion takeover of Asda in 2021 alongside private equity firm TDR Capital.

In recent months, the Issa brothers have divided their interests, with Zuber selling his 22.5% stake in Asda to TDR Capital in June. Zuber also stepped down as co-CEO of their forecourt business, EG Group, after acquiring the UK operations for £228 million, which he now runs independently. Despite the split, Mohsin has downplayed any rumours of a rift, maintaining that the brothers “get on exceptionally well.”

Applied Nutrition, which produces protein supplements and other sports nutrition products, is chaired by Andy Bell, founder of investment platform AJ Bell. The company has set the price range for its initial public offering (IPO) at between 136p and 160p per share, giving it an estimated valuation of between £340 million and £400 million.

Mohsin Issa joins a group of four prominent North West entrepreneurs backing the IPO, including Home Bargains founder Tom Morris and Liverpool property developer George Downing. Together, the investors are expected to hold up to 7% of the company following the IPO.

Applied Nutrition’s growth and upcoming stock market listing are further bolstered by a significant 32% stake from JD Sports, the Bury-based retail giant. Existing shareholders plan to sell approximately 137 million shares, valued at between £186 million and £220 million.

This investment marks another step in Issa’s post-Asda ventures, as he continues to focus on backing successful entrepreneurs and UK businesses. In a joint statement with his brother, Mohsin Issa said: “Our passion is backing great entrepreneurs and helping them to build strong UK businesses that drive growth and create jobs.”

Applied Nutrition did not comment directly on Issa’s involvement but is expected to benefit from his significant retail and entrepreneurial experience as it moves closer to its public listing.

Read more:
Former Asda boss Mohsin Issa invests £10m in sports supplement firm ahead of London IPO

Previous Post

IMF urges Rachel Reeves to raise taxes and rein in spending to stabilise UK public finances

Next Post

“Insurance Brokers Embrace Revolutionary Specialty Risk Assessment with PoRA”

Next Post

“Insurance Brokers Embrace Revolutionary Specialty Risk Assessment with PoRA”

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest

Jay Bhattacharya on Public Health

October 12, 2021

That Bangladesh Mask Study!

December 1, 2021

Antitrust Regulation Assumes Bureaucrats Know the “Correct” Amount of Competition

November 24, 2021
Pints of champagne could be the next ‘Brexit dividend’

Pints of champagne could be the next ‘Brexit dividend’

December 24, 2021
Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

0

0

0

0
Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

July 23, 2025
July 30 Event: Senators Tim Kaine and Rand Paul Discuss the Effects of Tariffs on the US Bourbon and Wine Industries

July 30 Event: Senators Tim Kaine and Rand Paul Discuss the Effects of Tariffs on the US Bourbon and Wine Industries

July 23, 2025

What Does It Really Cost to Buy a Franchise?

July 23, 2025

9 Top Marketing Strategies for Small Dental Clinics

July 23, 2025

Recent News

Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

Fifteen Years of Dodd-Frank: A Legacy of Missed Targets and Regulatory Overreach

July 23, 2025
July 30 Event: Senators Tim Kaine and Rand Paul Discuss the Effects of Tariffs on the US Bourbon and Wine Industries

July 30 Event: Senators Tim Kaine and Rand Paul Discuss the Effects of Tariffs on the US Bourbon and Wine Industries

July 23, 2025

What Does It Really Cost to Buy a Franchise?

July 23, 2025

9 Top Marketing Strategies for Small Dental Clinics

July 23, 2025

Disclaimer: ElonsVision.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • Contacts
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 ElonsVision. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 ElonsVision. All Rights Reserved.